Use the links on this page to access external information and learning resources relevant to your practice, including CME activity and links to international psoriasis organisation websites.
Expert insights: IL-17 inhibition in psoriasis care
This expert panel discuss the current available treatments for psoriasis, and provide a balanced argument for the use of IL-17 in the treatment of psoriasis patients. Within this accredited CME-activity the experts look at the current treatment pathways and how these have been adapted over time.
Perspectives in Psoriasis: Assessing Treatment Efficacy – Which Measures, What Do They Tell Us?
On completion of this accredited CME activity, participants should be able to outline efficacy measures commonly used in psoriasis clinical trial programs and clinical practice, evaluate optimal methods of employing efficacy assessment tools when treating patients and describe how efficacy measures used in the management of psoriasis correlate with each other.
Aiming Higher: Meeting the Needs of Patients
This CME-accredited activity from Medscape aims to improve physicians' knowledge on treatment goals, patient quality of life and new treatment options becoming available for psoriasis patients.
IL-17: A New Therapeutic Target in Psoriasis
The goal of this Medscape accredited-CME activity is to educate physicians on the emerging treatment paradigm for the optimal management of patients with psoriasis, including the evolving concepts in efficacy assessment, the role of novel agents, and strategies to improve physician-patient communication to ensure successful outcomes of therapy.